Australia's most trusted
source of pharma news
Saturday, 11 July 2026
Posted 10 July 2026 PM
Pfizer has beaten its rivals in the vaccine space to take the crown as industry's most popular pharma according to doctors, who are throwing their support behind companies as vaccination rates tumble.
ZoomRx's Pharma Manufacturer Perception Report for Vaccines surveyed 58 US-based HCPs and found a strong increase in the Net Promoter Scores (NPS) for pharmas in the vaccine space, which it attributed to stabilised supply and improved field execution.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.